AI Verdict
NTR has stronger fundamentals based on our AI analysis.
NTR vs NTLA Fundamental Comparison
| Metric | NTR | NTLA |
|---|---|---|
| Revenue | N/A | $67.7M |
| Net Income | N/A | $-412.7M |
| Net Margin | N/A | -609.9% |
| ROE | N/A | -61.5% |
| ROA | N/A | -49.0% |
| Current Ratio | N/A | 5.08x |
| Debt/Equity | N/A | 0.00x |
| EPS | N/A | $-3.81 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NTR vs NTLA: Frequently Asked Questions
Is NTR or NTLA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NTR has stronger fundamentals. NTR is rated HOLD (5% confidence) while NTLA is rated SELL (92% confidence). This is not investment advice.
How does NTR compare to NTLA fundamentally?
Nutrien Ltd. has ROE of N/A vs Intellia Therapeutics, Inc.'s -61.5%. Net margins are N/A vs -609.9% respectively.
Which stock pays higher dividends, NTR or NTLA?
NTR has a dividend yield of N/A or no dividend while NTLA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NTR or NTLA for long term?
For long-term investing, consider that NTR has HOLD rating with 5% confidence, while NTLA has SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NTR vs NTLA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NTR vs NTLA, the AI consensus favors NTR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.